Lifevantage Financial Activities - Other 2010-2025 | LFVN

Lifevantage financial activities - other from 2010 to 2025. Financial activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the financing activities section of the Cash Flows Statement.
Lifevantage Annual Financial Activities - Other
(Millions of US $)
2024 $-1
2023 $0
2022 $0
2021 $-1
2020 $-6
2019 $-3
2018 $0
2017 $N/A
2016 $0
2015 $0
2014 $-1
2013 $1
2012 $0
2011 $N/A
2010 $0
2009 $0
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.166B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $90.882B 21.95
Becton Dickinson (BDX) United States $50.744B 12.57
Cardinal Health (CAH) United States $36.723B 19.23
Straumann Holding AG (SAUHY) Switzerland $21.343B 0.00
Labcorp (LH) United States $20.908B 16.96
Cooper (COO) United States $16.380B 21.73
West Pharmaceutical Services (WST) United States $15.606B 32.71
Align Technology (ALGN) United States $13.398B 26.60
Henry Schein (HSIC) United States $8.744B 15.00
Merit Medical Systems (MMSI) United States $5.798B 28.03
DENTSPLY SIRONA (XRAY) United States $3.314B 9.90
CONMED (CNMD) United States $1.865B 13.95
STAAR Surgical (STAA) United States $0.953B 0.00
Pro-Dex (PDEX) United States $0.141B 15.44